While the chimeric ALK protein has been shown to activate the STAT3 pathway directly, ALK-negative forms of ALCL have been shown to commonly activate this pathway via mutations in JAK1, STAT3 and fusion proteins involving TYK2 and ROS1 [35]. The gene discussed is JAK1; the disease is anaplastic large cell lymphoma.